← Eichor
Study identifier: NCT06925269 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

DMD Voice: Qualitative Interviews With Patients and Caregivers

Condition: Duchenne Muscular Dystrophy (DMD)  ·  Sponsor: Red Nucleus Enterprise Solutions, LLC

PhaseN/A
Planned participants68
Who can joinMale, 10 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to understand DMD functional losses or abilities and their association with independence and quality of life from the perspective of individuals with DMD and/or and their caregivers. This is a qualitative interview study in which individuals with DMD and/or their caregivers will be asked to participate in a semi-structured, approximately 60- minute interview. Interviews will focus on functional abilities and independence. Caregivers and boys with DMD will be interviewed. This study includes no treatment nor intervention; however, some participants are being treated by a drug that is approved in the U.S. and the U.K. and under investigation in other geographies.

This description comes directly from the study's public registry record.

Talk to the study team

Mary Hubbard  ·  904-541-9326  ·  mhubbard@rednucleus.com

Always discuss trial participation with your own doctor first.

Locations (1)

Red NucleusYardley, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06925269